Allan M. Jordan
- Organic Chemistry top 0.5%
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 8
- Cancer therapeutics and mechanisms 7
- Histone Deacetylase Inhibitors Research 7
- Protein Degradation and Inhibitors 6
- DNA Repair Mechanisms 4
- Inorganic Chemistry top 2%
- Toxicology top 2%
- Pharmaceutical Science top 2%
-
- Computational Drug Discovery Methods 7
-
- PARP inhibition in cancer therapy 6
-
- Microtubule and mitosis dynamics 5
- Co-authors
- Stephen D. RoughleyNicholas J. LawrenceAlan T. McGownJohn A. HadfieldDonald OgilvieJames R. HitchinTim C. P. SomervailleGary J. Spencer
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Allan M. Jordan
60 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Organic Chemistry 2.7k
- Molecular Biology 2.5k
- Inorganic Chemistry 500
- Toxicology 91
- Pharmaceutical Science 146
Countries citing papers authored by Allan M. Jordan
This map shows the geographic impact of Allan M. Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan M. Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan M. Jordan more than expected).
Fields of papers citing papers by Allan M. Jordan
This network shows the impact of papers produced by Allan M. Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan M. Jordan. The network helps show where Allan M. Jordan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Allan M. Jordan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2021 | 1 | |
| 3 | 2018 | 137 | |
| 4 | 2017 | 3 | |
| 5 | 2017 | 13 | |
| 6 | 2017 | 10 | |
| 7 | 2016 | 10 | |
| 8 | 2014 | 37 | |
| 9 | 2012 | 15 | |
| 10 | The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cellsbreakdown → | 2012 | 432 |
| 11 | 2009 | 23 | |
| 12 | 2009 | 27 | |
| 13 | 2009 | 35 | |
| 14 | 2008 | 55 | |
| 15 | 2008 | 24 | |
| 16 | 2006 | 17 | |
| 17 | 2006 | 67 | |
| 18 | 2001 | 41 | |
| 19 | 1999 | 39 | |
| 20 | Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindlebreakdown → | 1998 | 570 |
About Allan M. Jordan
Allan M. Jordan is a scholar working on Physiology, Molecular Biology and Oncology, having authored 61 papers that have together received 4.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Cancer therapeutics and mechanisms (7 papers), Histone Deacetylase Inhibitors Research (7 papers), Computational Drug Discovery Methods (7 papers), PARP inhibition in cancer therapy (6 papers), Protein Degradation and Inhibitors (6 papers), Microtubule and mitosis dynamics (5 papers) and DNA Repair Mechanisms (4 papers). The work is most often cited by research in Organic Chemistry (2.7k citations), Molecular Biology (2.5k citations) and Inorganic Chemistry (500 citations). Allan M. Jordan has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Stephen D. Roughley, Nicholas J. Lawrence, Alan T. McGown, John A. Hadfield, Donald Ogilvie, James R. Hitchin, Tim C. P. Somervaille, Gary J. Spencer, Daniel P. Mould and Yaoyong Li. Their work appears in journals such as Journal of Clinical Oncology, Cancer Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.